Physician profile
Jonathan Chow
NPI 1275809261
$285,119.91
in general payments reported to CMS, 2019-2025
7 companies · $21K in 2025
The $21K reported for 2025 was more than what 98% of Critical Care Medicine (Anesthesiology) providers received nationally (typical 2025 total: $97.90).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $25K · 2021: $50K · 2022: $56K · 2023: $88K · 2024: $23K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $55K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $32K · Honoraria: $30K · Travel and Lodging: $14K · Food and Beverage: $1,060.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $55,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $32,137.50 |
| Honoraria | $30,148.00 |
| Travel and Lodging | $13,609.90 |
| Food and Beverage | $1,059.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $187,735.31 | 2019-2025 | Giapreza |
| Exthera Medical Corporation | $67,719.09 | 2022-2023 | |
| Hemosonics LLC | $29,049.44 | 2019-2025 | Qunatra Qplus System, Quantra Qplus System |
| Partner Therapeutics, INC. | $350.00 | 2020 | |
| Shionogi INC | $123.13 | 2022 | |
| Chiesi USA, INC. | $102.85 | 2019 | |
| Edwards Lifesciences Corporation | $40.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$61,509.67 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Chow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.